Biomarin Pharmaceutical Inc (BMRN)
82.00
-0.17
(-0.21%)
USD |
NASDAQ |
Apr 26, 11:25
Biomarin Pharmaceutical Total Assets (Quarterly): 6.842B for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 6.842B |
| September 30, 2023 | 6.758B |
| June 30, 2023 | 6.563B |
| March 31, 2023 | 6.434B |
| December 31, 2022 | 6.375B |
| September 30, 2022 | 6.264B |
| June 30, 2022 | 6.146B |
| March 31, 2022 | 6.063B |
| December 31, 2021 | 6.005B |
| September 30, 2021 | 5.977B |
| June 30, 2021 | 5.898B |
| March 31, 2021 | 5.805B |
| December 31, 2020 | 5.848B |
| September 30, 2020 | 6.158B |
| June 30, 2020 | 5.302B |
| March 31, 2020 | 4.723B |
| December 31, 2019 | 4.690B |
| September 30, 2019 | 4.558B |
| June 30, 2019 | 4.393B |
| March 31, 2019 | 4.435B |
| December 31, 2018 | 4.427B |
| September 30, 2018 | 4.695B |
| June 30, 2018 | 4.625B |
| March 31, 2018 | 4.597B |
| December 31, 2017 | 4.633B |
| Date | Value |
|---|---|
| September 30, 2017 | 4.581B |
| June 30, 2017 | 4.020B |
| March 31, 2017 | 3.939B |
| December 31, 2016 | 4.024B |
| September 30, 2016 | 3.842B |
| June 30, 2016 | 3.087B |
| March 31, 2016 | 3.667B |
| December 31, 2015 | 3.729B |
| September 30, 2015 | 3.625B |
| June 30, 2015 | 3.649B |
| March 31, 2015 | 3.659B |
| December 31, 2014 | 2.475B |
| September 30, 2014 | 2.440B |
| June 30, 2014 | 2.346B |
| March 31, 2014 | 2.341B |
| December 31, 2013 | 2.244B |
| September 30, 2013 | 1.621B |
| June 30, 2013 | 1.602B |
| March 31, 2013 | 1.598B |
| December 31, 2012 | 1.568B |
| September 30, 2012 | 1.567B |
| June 30, 2012 | 1.533B |
| March 31, 2012 | 1.297B |
| December 31, 2011 | 1.306B |
| September 30, 2011 | 1.295B |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
4.393B
Minimum
Jun 2019
6.842B
Maximum
Dec 2023
5.832B
Average
6.005B
Median
Dec 2021
Total Assets (Quarterly) Benchmarks
| Eli Lilly and Co | 64.01B |
| Merck & Co Inc | 106.68B |
| Pfizer Inc | 226.50B |
| Bristol-Myers Squibb Co | 95.16B |
| Moderna Inc | 18.43B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 1.890B |
| Shareholders Equity (Quarterly) | 4.952B |
| Debt to Equity Ratio | 0.2195 |
| Current Ratio | 2.512 |
| Net Debt Paydown Yield | -0.01% |